This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wertheimer, E. Articles by Tennenbaum, T. Search for Related Content PubMed PubMed Citation Articles by Wertheimer, E. Articles by Tennenbaum, T.

The Regulation of Skin Proliferation and Differentiation in the IR Null Mouse: Implications for Skin Complications of Diabetes¹

Department of Pathology, Sackler School of Medicine, Tel Aviv University (E.W., N.S., M.T., S.N.-M., G.S.), Tel Aviv 69978, Israel; Faculty of Life Sciences, Bar Ilan University (M.G., T.T.), Ramat Gan 52900, Israel; Columbia University/Berrie Research Pavilion (D.A.), New York, New York 10032; and Department of Pathology, E. Wolfson Medical Center (I.A., S.N.-M.), Holon 58100, Israel

Address all correspondence and requests for reprints to: Efrat Wertheimer, M.D. Ph.D., Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel. E-mail: effy{at}patholog tau.ac.il.

Impaired wound healing of skin is one of the most serious complications of diabetes. However, the pathogenesis of this process is not known, and it is unclear whether impaired insulin signaling could directly affect skin physiology. To elucidate the role of insulin in skin, we studied skin insulin receptor (IR) null mice. The morphology of the skin of newborn IR null mice was normal; however, these mice exhibited decreased proliferation of skin keratinocytes and changes in expression of skin differentiation markers. Due to the short life span of the IR null mice, further characterization was performed in cultured skin keratinocytes that can be induced to differentiate in vitro, closely following the maturation pattern of epidermis in vivo. It was found that despite a compensatory increase in the insulin-like growth factor I receptor autophosphorylation, differentiation of cultured IR null keratinocytes was markedly impaired. In vitro proliferation was not affected as much. Furthermore, although the basal glucose transport system of the null mice was not defective, the insulin-induced increase in glucose transport was abrogated. These results suggest that insulin regulates, via the IR, the differentiation and glucose transport of skin keratinocytes, whereas proliferation is affected by the diabetes milieu of IR knockout mice.

This article has been cited by other articles:

				M. Sadagurski, S. Yakar, G. Weingarten, M. Holzenberger, C. J. Rhodes, D. Breitkreutz, D. LeRoith, and E. Wertheimer Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol. Cell. Biol., April 1, 2006; 26(7): 2675 - 2687. [Abstract] [Full Text] [PDF]

				I. Goren, E. Muller, J. Pfeilschifter, and S. Frank Severely Impaired Insulin Signaling in Chronic Wounds of Diabetic ob/ob Mice: A Potential Role of Tumor Necrosis Factor-{alpha} Am. J. Pathol., March 1, 2006; 168(3): 765 - 777. [Abstract] [Full Text] [PDF]

				M. Gartsbein, A. Alt, K. Hashimoto, K. Nakajima, T. Kuroki, and T. Tennenbaum The role of protein kinase C {delta} activation and STAT3 Ser727 phosphorylation in insulin-induced keratinocyte proliferation J. Cell Sci., February 1, 2006; 119(3): 470 - 481. [Abstract] [Full Text] [PDF]

				M. Sadagurski, G. Weingarten, C. J. Rhodes, M. F. White, and E. Wertheimer Insulin Receptor Substrate 2 Plays Diverse Cell-specific Roles in the Regulation of Glucose Transport J. Biol. Chem., April 15, 2005; 280(15): 14536 - 14544. [Abstract] [Full Text] [PDF]

				S. Corbetta, G. Bulfamante, D. Cortelazzi, V. Barresi, I. Cetin, G. Mantovani, S. Bondioni, P. Beck-Peccoz, and A. Spada Adiponectin Expression in Human Fetal Tissues during Mid- and Late Gestation J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2397 - 2402. [Abstract] [Full Text] [PDF]

				A. Entingh-Pearsall and C. R. Kahn Differential Roles of the Insulin and Insulin-like Growth Factor-I (IGF-I) Receptors in Response to Insulin and IGF-I J. Biol. Chem., September 3, 2004; 279(36): 38016 - 38024. [Abstract] [Full Text] [PDF]

				S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems Endocr. Rev., December 1, 2003; 24(6): 737 - 764. [Abstract] [Full Text] [PDF]

				E. Assa-Kunik, D. Fishman, S. Kellman-Pressman, S. Tsory, S. Elhyany, O. Baharir, and S. Segal Alterations in the Expression of MHC Class I Glycoproteins by B16BL6 Melanoma Cells Modulate Insulin Receptor-Regulated Signal Transduction and Augments Resistance to Apoptosis J. Immunol., September 15, 2003; 171(6): 2945 - 2952. [Abstract] [Full Text] [PDF]